Literature DB >> 6167446

Estimation of differential in vitro sensitivity of non-Hodgkin lymphomas to anticancer drugs.

O Sanfilippo, M G Daidone, A Costa, R Canetta, R Silvestrini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6167446     DOI： 10.1016/0014-2964(81)90039-6

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  7 in total

1.  Absolute and relative activities of platinum-complexes on human tumors as evaluated by an antimetabolic in vitro assay.

Authors:  M G Daidone; R Silvestrini; N Zaffaroni; E Grignolio; F Landoni
Journal:  Invest New Drugs       Date:  1987       Impact factor: 3.850

Review 2.  Predictive tests in cancer chemotherapy. A reappraisal.

Authors:  R Osieka; S Seeber; C G Schmidt
Journal:  Klin Wochenschr       Date:  1984-03-01

3.  Heterotransplant mouse model cohorts of human malignancies: A novel platform for Systematic Preclinical Efficacy Evaluation of Drugs (SPEED).

Authors:  Ashutosh K Pathak; Manisha Bhutani; Pierre Saintigny; Li Mao
Journal:  Am J Transl Res       Date:  2009-01-01       Impact factor: 4.060

4.  New possibilities of cytostatic drug testing on patient tumor cells by flow cytometry.

Authors:  G Valet; H H Warnecke; H Kahle
Journal:  Blut       Date:  1984-07

Review 5.  [Predictive tumor tests in chemotherapeutic treatment concepts of malignant diseases].

Authors:  K Possinger; H Ehrhart
Journal:  Klin Wochenschr       Date:  1983-01-17

6.  A comparison of three assays used for the in vitro chemosensitivity testing of human tumours.

Authors:  A P Wilson; C H Ford; C E Newman; A Howell
Journal:  Br J Cancer       Date:  1984-01       Impact factor: 7.640

7.  The response of tumour cells to radiation and cytotoxic drugs--a comparison of clonogenic and isotope uptake assays.

Authors:  P R Twentyman; G A Walls; K A Wright
Journal:  Br J Cancer       Date:  1984-11       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.